Delivery Order SPE2DR25D3101-SPE2DR26F5M10
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,039.39 to AmerisourceBergen Drug Corp for Propranolol ER 60 mg capsules (100-count units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count) on August 6, 2025, with a ceiling value of $12,757.00 and completion date of August 7, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and specifies Conshohocken, Pennsylvania as the place of performance, which is also the vendor's corporate headquarters location. The delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for propranolol ER 80 mg capsules (100-count units) with a ceiling value of $13,151.79. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by September 23, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $2,431.80 delivery order to AmerisourceBergen Drug Corp for Propranolol ER 80 mg capsules (100 count) on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $10,610.82 delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Propranolol ER 160 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,426.17 to AmerisourceBergen Drug Corp for Propranolol ER 80 mg capsules (100-count units) on May 20, 2025, with completion scheduled for May 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's larger federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Propranolol ER 160 mg capsules in quantities of 100 units, with a contract ceiling value of $7,012.89. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award based on open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Propranolol ER 60 mg capsules (100-count bottles) with a ceiling value of $3,180.83. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through an open competition process. The order is set to complete by May 21, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, which serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) valued at $12,950.60 under a firm fixed-price contract type. The award was made through a competitive process with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the designated place of performance—will fulfill this pharmaceutical delivery order as part of its ongoing...
- The Defense Logistics Agency awarded a $2,467.00 delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 80 mg capsules (100-count units) with a firm fixed price contract structure. This non-set-aside award was executed on May 30, 2025, with an ultimate completion date of June 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical supply requirement fulfilled...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5M10Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on November 13, 2025, for Propranolol ER 80 mg capsules (1,000 units) valued at $1,300.04. The award carries a firm fixed price structure with an ultimate completion date of November 14, 2025, and represents a non-set-aside procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. This delivery order for propranolol, a cardiovascular medication used in managing hypertension and other cardiac conditions, exemplifies the company's role as a critical vendor in the federal medical supply chain. AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition and its extensive portfolio of pharmaceutical deliveries position it as a key provider within the DLA's medical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/13/25 |